FUNDAMENTALS · Fundamentals · US Healthcare

Innovage Holding (INNV) Fundamentals 2026 — Revenue Analysis | SniperIQ

Innovage Holding (INNV) is a US-listed Healthcare company in Medical - Care Facilities with a market capitalization of

.6B, trading at
1.68 on the NASDAQ. This SniperIQ fundamentals page covers Innovage Holding's valuation, profitability (net margin -2.3%), revenue ($854M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Market Cap
.6B
Net Margin-2.3%
Revenue (FY25)$854M

Full research coverage

  • 8-Quarter Revenue & Margin Trend
  • Debt Maturity & Coverage
  • Peer Valuation Comparison
  • Free Cash Flow & Owner Earnings
  • AI Signal + Institutional Flow
  • DCF Valuation Model

Frequently Asked Questions

What is Innovage Holding's market cap?

Innovage Holding (INNV) has a market capitalization of approximately

.6B, trading at
1.68 on the NASDAQ. Market cap moves with the live share price.

What is Innovage Holding's P/E ratio?

Innovage Holding's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 6.9x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is Innovage Holding?

Innovage Holding runs a net profit margin of -2.3%, a gross margin of 20.7%, and an operating margin of 3.9%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does Innovage Holding generate?

Innovage Holding reported revenue of $854M for fiscal year 2025, with net income of -

0M and earnings per share (EPS) of -0.22. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does Innovage Holding pay a dividend?

Innovage Holding does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.

Is Innovage Holding financially healthy?

Innovage Holding carries a debt-to-equity ratio of 0.41x and a current ratio of 1.03x, with a market beta of 0.35. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is Innovage Holding a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Innovage Holding (INNV) the key facts are: market cap

.6B, revenue $854M, 52-week range 3.13-12.64. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.

Track Innovage Holding's full fundamentals live

Get Innovage Holding's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.

Related: Thonburi Medical Centre Public (KDH) fundamentals · Precigen (PGEN) fundamentals · Teladoc Health (TDOC) fundamentals · MoonLake Immunotherapeutics (MLTX) fundamentals · All stock fundamentals · AI signal library
Research Hubs: Fundamentals library · Screeners · Institutional positioning · Super investors · Daily signals · Platform comparisons